Literatur
- 1
Daubin C, Parienti J J, Vincent S. et al .
Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated
patients: a prospective cohort study.
Crit Care.
2006;
10
R142
- 2
Schlosser B M, Borg I, Rohde G. et al .
Virale und bakteriologische Besiedlung bei frisch intubierten Patienten sowie im Verlauf
auf der Intensivstation.
Pneumologie.
2006;
60 [S1]
S77
- 3
Ong G M, Lowry K, Mahajan S. et al .
Herpes simplex type 1 shedding is associated with reduced hospital survival in patients
receiving assisted ventilation in a tertiary referral intensive care unit.
J Med Virol.
2004;
72
121-125
- 4
Camps K, Jorens P G, Demey H E, Pattyn S R, Ieven M.
Clinical significance of herpes simplex virus in the lower respiratory tract of critically
ill patients.
Eur J Clin Microbiol Infect Dis.
2002;
21
758-759
- 5
Maris N A, de Vos A F, Dessing M C. et al .
Antiinflammatory Effects of Salmeterol after Inhalation of Lipopolysaccharide by Healthy
Volunteers.
American Journal of Respiratory and Critical Care Medicine.
2005;
172
878-884
- 6
Daubin C, Vincent S, Vabret A. et al .
Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective
cohort study.
Intensive Care Med.
2005;
31
1116-1122
- 7
Gray R D, MacGregor G, Noble D. et al .
Sputum proteomics in inflammatory and suppurative respiratory diseases.
AmJ RespirCrit Care Med.
2008;
178
444-452
- 8
Hanley P J, Conaway M M, Halstead D C, Rhodes 3rd L V, Reed 3rd J .
Nosocomial herpes simplex virus infection associated with oral endotracheal intubation.
Am J Infect Control.
1993;
21
310-316
- 9
Byers R J, Hasleton P S, Quigley A. et al .
Pulmonary herpes simplex in burns patients.
Eur Respir J.
1996;
9
2313-2317
- 10
Bruynseels P, Jorens P G, Demey H E. et al .
Herpes simplex virus in the respiratory tract of critical care patients: a prospective
study.
Lancet.
2003;
362
1536-1541
- 11
Diederen B MW, van der Valk P DLPM, Kluytmans J AWJ, Peeters M F, Hendrix R.
The role of atypical respiratory pathogens in exacerbations of chronic obstructive
pulmonary disease.
Eur Respir J.
2007;
30
240-244
- 12
Lutsky B N, Schuller J L, Cerio R. et al .
Comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension
in the treatment of chronic allergic skin diseases in a pediatric population.
Arzneimittelforschung.
1993;
43
1196-1199
- 13
Engelmann I, Gottlieb J, Meier A. et al .
Clinical relevance of and risk factors for HSV-related tracheobronchitis or pneumonia:
results of an outbreak investigation.
Crit Care.
2007;
11
R119
- 14
Tuxen D V, Wilson J W, Cade J F.
Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients
with the adult respiratory distress syndrome.
Am Rev Respir Dis.
1987;
136
402-405
- 15
van den Brink J W, Simoons-Smit A M, Beishuizen A, Girbes A R, Strack van Schijndel
R J, Groeneveld A B.
Respiratory herpes simplex virus type 1 infection/colonisation in the critically ill:
marker or mediator?.
J Clin Virol.
2004;
30
68-72
- 16
Ziemann M, Sedemund-Adib B, Reiland P, Schmucker P, Hennig H.
Increased mortality in long-term intensive care patients with active cytomegalovirus
infection.
Crit Care Med.
2008;
36
3145-3150
- 17
Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, Hamprecht K.
Human cytomegalovirus infections in nonimmunosuppressed critically ill patients.
Crit Care Med.
2001;
29
541-547
- 18
Jaber S, Chanques G, Borry J. et al .
Cytomegalovirus infection in critically ill patients: associated factors and consequences.
Chest.
2005;
127
233-241
- 19
Guidry G G, Black-Payne C A, Payne D K, Jamison R M, George R B, Bocchini Jr. J A.
Respiratory syncytial virus infection among intubated adults in a university medical
intensive care unit.
Chest.
1991;
100
1377-1384
- 20
Oliveira E C, Lee B, Colice G L.
Influenza in the intensive care unit.
J Intensive Care Med.
2003;
18
80-91
- 21
Malcolm E, Arruda E, Hayden F G, Kaiser L.
Clinical features of patients with acute respiratory illness and rhinovirus in their
bronchoalveolar lavages.
J Clin Virol.
2001;
21
9-16
- 22
Stollenwerk N, Harper R W, Sandrock C E.
Bench-to-bedside review: rare and common viral infections in the intensive care unit-linking
pathophysiology to clinical presentation.
Crit Care.
2008;
12
219
- 23
Stolz D, Christ-Crain M, Bingisser R. et al .
Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing
procalcitonin-guidance with standard therapy.
Chest.
2007;
131
9-19
- 24
Christ-Crain M, Stolz D, Bingisser R. et al .
Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized
trial.
Am J Respir Crit Care Med.
2006 1;
174
84-93
- 25
Harbarth S TEP, Holeckova K ATA, Froidevaux C ELI. et al .
Diagnostic Value of Procalcitonin, Interleukin-6, and Interleukin-8 in Critically
Ill Patients Admitted with Suspected Sepsis.
American Journal of Respiratory and Critical Care Medicine.
2001;
164
396-402
- 26
Rohde G, Drosten C, Borg I. et al .
Detection of Respiratory Viruses – How, When, Where and Why?.
Pneumologie.
2009;
63
14-22
- 27
Agoritsas K, Mack K, Bonsu B K, Goodman D, Salamon D, Marcon M J.
Evaluation of the Quidel QuickVue test for detection of influenza A and B viruses
in the pediatric emergency medicine setting by use of three specimen collection methods.
J Clin Microbiol.
2006;
44
2638-2641
- 28
Grijalva C G, Poehling K A, Edwards K M. et al .
Accuracy and interpretation of rapid influenza tests in children.
Pediatrics.
2007;
119
e6-e11
- 29
van Kraaij M G, van Elden L J, van Loon A M. et al .
Frequent detection of respiratory viruses in adult recipients of stem cell transplants
with the use of real-time polymerase chain reaction, compared with viral culture.
Clin Infect Dis.
2005;
40
662-669
- 30
Reijans M, Dingemans G, Klaassen C H. et al .
RespiFinder: a New Multiparameter Test To Differentially Identify Fifteen Respiratory
Viruses.
Journal of Clinical Microbiology.
2008;
46
1232-1240
- 31
Rohde G.
Therapeutic targets in respiratory viral infections.
Curr Med Chem.
2007;
14
2776-2782
- 32
Jefferson T, Jones M, Doshi P, Del Mar C.
Neuraminidase inhibitors for preventing and treating influenza in healthy adults:
systematic review and meta-analysis.
BMJ.
2009;
339
b5106
- 33
Moscona A.
Medical management of influenza infection.
Annu Rev Med.
2008;
59
397-413
- 34
Treanor J J, Hayden F G, Vrooman P S. et al .
for the USONSG. Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir
in Treating Acute Influenza: A Randomized Controlled Trial.
JAMA.
2000;
283
1016-1024
- 35
Godlee F, Clarke M.
Why don’t we have all the evidence on oseltamivir?.
BMJ.
2009;
339
b5351
- 36
Ventre K, Randolph A.
Ribavirin for respiratory syncytial virus infection of the lower respiratory tract
in infants and young children.
Cochrane Database Syst Rev.
2004;
CD000181
- 37
Jefferson T, Del Mar C, Dooley L. et al .
Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic
review.
BMJ.
2009;
339
b3675
- 38
Hayward A C, Harling R, Wetten S. et al .
Effectiveness of an influenza vaccine programme for care home staff to prevent death,
morbidity, and health service use among residents: cluster randomised controlled trial.
BMJ.
2006;
333
1241
Prof. Dr. G. Rohde
Maastricht University Medical Center
Department of Respiratory Medicine
Postbus 5800
6202AZ Maastricht
Niederlande
eMail: g.rohde@mumc.nl
